UCSF home page UCSF home page About UCSF UCSF Medical Center
UCSF navigation bar
photos

Faculty Profiles

Rupal Shah, MD
M_MED-PULM-CORE
Assistant Professor

350 Parnassus
San Francisco, CA 94117

Rupal.Shah@ucsf.edu

Dr. Rupal Shah is Assistant Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. She serves as an attending physician in the Lung Transplant Program and the Interstitial Lung Disease Program. She specializes in care of patients with advanced lung disease, both before and after lung transplantation.
Dr. Shah received her undergraduate degree from University of Michigan, and a Masters in Clinical Epidemiology from University of Pennsylvania. She completed medical school at Wayne State University School of Medicine and did her internal medicine residency at Columbia University and advanced training in pulmonary and critical care medicine at University of Pennsylvania. She is board certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine.

Education and Training

Location Degree or Training Specialty Date
University of Pennsylvania Pulmonary and Critical Care 2012
NYP-Columbia University Internal Medicine 2008
Wayne State University School of Medicine 2005

Interests

Advanced Lung Disease, Chronic Rejection, Interstitial Lung Disease, Lung Transplantation, Primary Graft Dysfunction

Recent Articles (31)

Farrand E, Shah R, Collard H. The Hospitalized Patient with Interstitial Lung Disease: A Hospitalist Primer. J Hosp Med. 2017 Jul; 12(7):580-584.

Shah RJ, Boin F. Lung Transplantation in Patients With Systemic Sclerosis. Curr Rheumatol Rep. 2017 May; 19(5):23.

Singer JP, Katz PP, Soong A, Shrestha P, Huang D, Ho J, Mindo M, Greenland JR, Hays SR, Golden J, Kukreja J, Kleinhenz ME, Shah RJ, Blanc PD. Effect of Lung Transplantation on Health-Related Quality of Life in the Era of the Lung Allocation Score: A U.S. Prospective Cohort Study. Am J Transplant. 2017 May; 17(5):1334-1345.

Patterson KC, Shah RJ, Porteous MK, Christie JD, D'Errico CA, Chadwick M, Triano MJ, Deshpande C, Rossman MD, Litzky LA, Kreider M, Miller WT. Interstitial Lung Disease in the Elderly. Chest. 2017 Apr; 151(4):838-844.

Del Signore AG, Shah RN, Gupta N, Altman KW, Woo P. Complications and Failures of Office-Based Endoscopic Angiolytic Laser Surgery Treatment. J Voice. 2016 Nov; 30(6):744-750.

Adams KN, Shah RN, Buckmire RA. Stricture location predicts swallowing outcomes following endoscopic rendezvous procedures. Laryngoscope. 2017 Jun; 127(6):1388-1391.

Porteous MK, Ky B, Kirkpatrick JN, Shinohara R, Diamond JM, Shah RJ, Lee JC, Christie JD, Kawut SM. Diastolic Dysfunction Increases the Risk of Primary Graft Dysfunction after Lung Transplant. Am J Respir Crit Care Med. 2016 Jun 15; 193(12):1392-400.

Kassutto SM, Dine CJ, Kreider M, Shah RJ. Changing the Ambulatory Training Paradigm. Design and Implementation of an Outpatient Pulmonology Fellowship Curriculum. Ann Am Thorac Soc. 2016 Apr; 13(4):540-4.

Shah RN, Slaughter KA, Fedore LW, Huang BY, Deal AM, Buckmire RA. Does residual wall size or technique matter in the treatment of Zenker's diverticulum? Laryngoscope. 2016 Nov; 126(11):2475-2479.

Diamond JM, Porteous MK, Roberts LJ, Wickersham N, Rushefski M, Kawut SM, Shah RJ, Cantu E, Lederer DJ, Chatterjee S, Lama VN, Bhorade S, Crespo M, McDyer J, Wille K, Orens J, Weinacker A, Arcasoy S, Shah PD, Wilkes DS, Hage C, Palmer SM, Snyder L, Calfee CS, Ware LB, Christie JD. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia. J Heart Lung Transplant. 2016 Apr; 35(4):500-507.

Diamond JM, Shah RJ, Cantu E, Porteous MK, Christie JD. Survey of Lung Transplant Community's Views on Primary Graft Dysfunction. Am J Transplant. 2016 Feb; 16(2):724-6.

Kassutto SM, Shah RJ. Patient Satisfaction: Why and How Patients Grade You and Your Pulmonary Practice. Chest. 2015 Sep; 148(3):833-838.

Shah RJ, Diamond JM, Cantu E, Flesch J, Lee JC, Lederer DJ, Lama VN, Orens J, Weinacker A, Wilkes DS, Roe D, Bhorade S, Wille KM, Ware LB, Palmer SM, Crespo M, Demissie E, Sonnet J, Shah A, Kawut SM, Bellamy SL, Localio AR, Christie JD. Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation. Am J Transplant. 2015 Aug; 15(8):2188-96.

Singer JP, Peterson ER, Snyder ME, Katz PP, Golden JA, D'Ovidio F, Bacchetta M, Sonett JR, Kukreja J, Shah L, Robbins H, Van Horn K, Shah RJ, Diamond JM, Wickersham N, Sun L, Hays S, Arcasoy SM, Palmer SM, Ware LB, Christie JD, Lederer DJ. Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med. 2014 Nov 01; 190(9):1012-21.

Cantu E, Shah RJ, Lin W, Daye ZJ, Diamond JM, Suzuki Y, Ellis JH, Borders CF, Andah GA, Beduhn B, Meyer NJ, Ruschefski M, Aplenc R, Feng R, Christie JD. Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg. 2015 Feb; 149(2):596-602.

Shah RJ, Emtiazjoo AM, Diamond JM, Smith PA, Roe DW, Wille KM, Orens JB, Ware LB, Weinacker A, Lama VN, Bhorade SM, Palmer SM, Crespo M, Lederer DJ, Cantu E, Eckert GJ, Christie JD, Wilkes DS. Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation. Am J Respir Crit Care Med. 2014 Jun 15; 189(12):1564-7.

Cohen DG, Christie JD, Anderson BJ, Diamond JM, Judy RP, Shah RJ, Cantu E, Bellamy SL, Blumenthal NP, Demissie E, Hopkins RO, Mikkelsen ME. Cognitive function, mental health, and health-related quality of life after lung transplantation. Ann Am Thorac Soc. 2014 May; 11(4):522-30.

Diamond JM, Akimova T, Kazi A, Shah RJ, Cantu E, Feng R, Levine MH, Kawut SM, Meyer NJ, Lee JC, Hancock WW, Aplenc R, Ware LB, Palmer SM, Bhorade S, Lama VN, Weinacker A, Orens J, Wille K, Crespo M, Lederer DJ, Arcasoy S, Demissie E, Christie JD. Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction. Am J Respir Crit Care Med. 2014 Mar 01; 189(5):567-75.

Shah RJ, Wickersham N, Lederer DJ, Palmer SM, Cantu E, Diamond JM, Kawut SM, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Shah P, Arcasoy S, Wilkes DS, Christie JD, Ware LB. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation. Am J Transplant. 2014 Feb; 14(2):446-52.

Shah RJ, Christie JD. Response. Chest. 2014 Jan; 145(1):193.

Shah RJ, Diamond JM, Cantu E, Lee JC, Lederer DJ, Lama VN, Orens J, Weinacker A, Wilkes DS, Bhorade S, Wille KM, Ware LB, Palmer SM, Crespo M, Localio AR, Demissie E, Kawut SM, Bellamy SL, Christie JD. Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation. Chest. 2013 Aug; 144(2):616-622.

Shah RJ, Kotloff RM. Lung transplantation for obstructive lung diseases. Semin Respir Crit Care Med. 2013 Jun; 34(3):288-96.

Cantu E, Lederer DJ, Meyer K, Milewski K, Suzuki Y, Shah RJ, Diamond JM, Meyer NJ, Tobias JW, Baldwin DA, Van Deerlin VM, Olthoff KM, Shaked A, Christie JD. Gene set enrichment analysis identifies key innate immune pathways in primary graft dysfunction after lung transplantation. Am J Transplant. 2013 Jul; 13(7):1898-904.

Shah RJ, Kotloff RM. Beware of gloved fingers. Ann Am Thorac Soc. 2013 Feb; 10(1):56-8.

Shah RJ, Bellamy SL, Lee JC, Cantu E, Diamond JM, Mangalmurti N, Kawut SM, Ware LB, Christie JD. Early plasma soluble receptor for advanced glycation end-product levels are associated with bronchiolitis obliterans syndrome. Am J Transplant. 2013 Mar; 13(3):754-9.

Diamond JM, Lee JC, Kawut SM, Shah RJ, Localio AR, Bellamy SL, Lederer DJ, Cantu E, Kohl BA, Lama VN, Bhorade SM, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Shah AS, Weinacker A, Arcasoy S, Shah PD, Wilkes DS, Ware LB, Palmer SM, Christie JD. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013 Mar 01; 187(5):527-34.

Diamond JM, Porteous MK, Cantu E, Meyer NJ, Shah RJ, Lederer DJ, Kawut SM, Lee J, Bellamy SL, Palmer SM, Lama VN, Bhorade SM, Crespo M, Demissie E, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Arcasoy S, Wilkes DS, Ware LB, Christie JD. Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation. PLoS One. 2012; 7(12):e51932.

Shah RJ, Diamond JM, Lederer DJ, Arcasoy SM, Cantu EM, Demissie EJ, Kawut SM, Kohl B, Lee JC, Sonett J, Christie JD, Ware LB. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation. Transl Res. 2012 Dec; 160(6):435-42.

Diamond JM, Meyer NJ, Feng R, Rushefski M, Lederer DJ, Kawut SM, Lee JC, Cantu E, Shah RJ, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Weill D, Arcasoy S, Shah PD, Belperio JA, Wilkes D, Ware LB, Palmer SM, Christie JD. Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2012 Sep 15; 186(6):546-52.

Shah RJ, Bellamy SL, Localio AR, Wickersham N, Diamond JM, Weinacker A, Lama VN, Bhorade S, Belperio JA, Crespo M, Demissie E, Kawut SM, Wille KM, Lederer DJ, Lee JC, Palmer SM, Orens J, Reynolds J, Shah A, Wilkes DS, Ware LB, Christie JD. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. J Heart Lung Transplant. 2012 Sep; 31(9):942-9.

  Select data provided by UCSF Profiles, powered by CTSI at UCSF. Learn more about the data source.